The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare expenditures and the increasing prevalence of chronic diseases, particularly in emerging economies. The branded generics market has witnessed remarkable growth over recent …